Specialized Vascular Interventional Therapy for Liver Cancer and Cirrhosis Complications
Liver cancer and liver cirrhosis are closely linked — the majority of hepatocellular carcinoma (HCC) cases arise in patients with underlying cirrhosis, and cirrhosis itself causes a cascade of life-threatening complications including portal hypertension, esophageal varices, and ascites. Effective management requires expertise in both tumor-directed interventional therapy and vascular interventional treatment of cirrhosis complications. At Zhongshan Hospital in Shanghai, Dr. Luo Jianjun leads the vascular interventional subspecialty with deep expertise in both domains.
Featured Specialist: Dr. Luo Jianjun (罗剑钒)
Dr. Luo Jianjun is Associate Chief Physician and Director of the Vascular Interventional Subspecialty at the Department of Interventional Radiology, Zhongshan Hospital, Fudan University (Fudan Daxue Fushu Zhongshan Yiyuan) — one of China's most prestigious academic medical centers and a nationally designated key center for liver disease, hepatobiliary surgery, and interventional medicine.
Dr. Luo's clinical expertise spans two closely related areas:
- Interventional diagnosis and treatment of liver cancer (HCC) — locoregional therapies including TACE, ablation, and hepatic arterial infusion
- Interventional management of portal hypertension in liver cirrhosis — vascular procedures to manage the life-threatening complications of advanced liver disease
Interventional Treatment for Liver Cancer (HCC)
At Zhongshan Hospital — home to Prof. Fan Jia and Prof. Zhou Jian's world-renowned hepatobiliary surgery program — Dr. Luo's interventional oncology team plays a critical role in the multidisciplinary management of liver cancer, providing locoregional therapy for patients who are not immediate surgical candidates and bridging therapy for those awaiting surgery or transplantation.
- Transarterial chemoembolization (TACE): Catheter-directed delivery of chemotherapy and embolic agents into the tumor's hepatic arterial supply — the standard of care for intermediate-stage HCC (BCLC-B)
- Drug-eluting bead TACE (DEB-TACE): Advanced microsphere-based TACE for more sustained drug release and reduced systemic toxicity
- Radiofrequency ablation (RFA) and microwave ablation (MWA): Thermal ablation for small HCC tumors (≤3 cm), achieving outcomes comparable to surgical resection
- Combined TACE + ablation: Sequential therapy for tumors 3–5 cm — TACE reduces vascularity and heat-sink effect, improving ablation completeness
- Hepatic arterial infusion chemotherapy (HAIC): Continuous high-dose FOLFOX infusion via implanted hepatic arterial port for advanced HCC, including cases with portal vein tumor thrombus
- Bridging therapy: Locoregional treatment to control tumor growth while patients await liver transplantation or surgical resection
- Downstaging therapy: Reducing tumor burden to bring patients within transplant or resection eligibility criteria
Portal Hypertension: The Cirrhosis Complication That Threatens Life
Portal hypertension — elevated pressure in the portal venous system due to cirrhosis — is responsible for the most dangerous complications of advanced liver disease:
- Esophageal and gastric varices: Dilated veins in the esophagus and stomach that can rupture and cause life-threatening hemorrhage
- Ascites: Accumulation of fluid in the abdominal cavity, causing discomfort, infection risk, and respiratory compromise
- Hepatic encephalopathy: Neurological dysfunction from toxins that bypass the liver through portosystemic shunts
- Hepatorenal syndrome: Kidney failure secondary to severe portal hypertension
Vascular Interventional Procedures for Portal Hypertension
Dr. Luo's vascular interventional expertise addresses portal hypertension through minimally invasive procedures that reduce portal pressure and manage its complications:
Transjugular Intrahepatic Portosystemic Shunt (TIPS)
- A stent is placed between the portal vein and hepatic vein through the jugular vein, creating an artificial channel that reduces portal pressure
- Highly effective for refractory ascites and acute variceal hemorrhage
- Can be performed as an emergency procedure for acute bleeding
- Covered stent TIPS (PTFE-covered) provides superior long-term patency
Balloon-Occluded Retrograde Transvenous Obliteration (BRTO)
- Sclerotherapy of gastric varices via a retrograde venous approach
- Particularly effective for gastric fundal varices that are difficult to treat endoscopically
- May improve liver function by redirecting portal blood flow to the liver
Partial Splenic Embolization (PSE)
- Embolization of a portion of the splenic artery to reduce hypersplenism and portal pressure
- Improves thrombocytopenia and leukopenia caused by hypersplenism
- Enables patients to tolerate systemic chemotherapy or antiviral therapy
Variceal Embolization
- Direct embolization of esophageal or gastric varices via transhepatic or transjugular approach
- For patients with active or high-risk variceal bleeding not amenable to endoscopic treatment
The Zhongshan Hospital Advantage
Zhongshan Hospital's interventional radiology department operates within one of China's most comprehensive liver disease ecosystems, enabling seamless multidisciplinary coordination with:
- Prof. Fan Jia and Prof. Zhou Jian's hepatobiliary surgery team (liver resection and transplantation)
- Hepatology and liver disease specialists for cirrhosis management
- Medical oncology for systemic therapy coordination
- Endoscopy for combined endoscopic and interventional variceal management
How CMCS Coordinates Your Care
China Medical Concierge Shanghai (CMCS) is a health management company — not a hospital. We connect international patients with Shanghai's leading interventional specialists, including Dr. Luo Jianjun at Zhongshan Hospital, and manage every step of the process:
- Review of existing liver imaging (MRI, CT, ultrasound), liver function tests, tumor markers, and endoscopy reports
- Interventional treatment planning consultation with Dr. Luo's team
- Coordination with hepatobiliary surgery and hepatology for integrated management
- Appointment scheduling with priority access
- Medical interpretation during consultations and procedures
- Logistics support: accommodation near Zhongshan Hospital, visa assistance, and local transport
- Post-procedure follow-up and remote monitoring coordination
Get in Touch
If you have liver cancer, cirrhosis with portal hypertension complications, or variceal bleeding and are exploring interventional treatment options in Shanghai, contact our team for a confidential consultation.
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
0 comentarios